Prediction of chances for success or complications in gonadotrophin ovulation induction in normogonadotrophic anovulatory infertility

Reproductive BioMedicine Online

Volumn 7, Issue 2, 2003, Pages 170-178

  Mulders, Annemarie G M G J ^a   Eijkemans, Marinus J C ^a   Imani, Babak ^a   Fauser, Bart C J M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Anovulation; Exogenous gonadotrophin induction of ovulation; Follow up studies; Infertility; Polycystic ovary syndrome; Prediction model

Indexed keywords

ANDROSTENEDIONE; CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; FOLLITROPIN; GESTAGEN; GONADOTROPIN; GONAL-F; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN; TESTOSTERONE; UROFOLLITROPIN;

ADULT; ANDROSTENEDIONE BLOOD LEVEL; ANOVULATION; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFICACY; FEMALE; FEMALE INFERTILITY; FOLLOW UP; HUMAN; LOW DRUG DOSE; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OVARY FOLLICLE DEVELOPMENT; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREDICTION; PREGNANCY; REGRESSION ANALYSIS; REPRODUCTIVE SUCCESS; SCREENING; SINGLE DRUG DOSE; TESTOSTERONE BLOOD LEVEL; TREATMENT OUTCOME; WITHDRAWAL BLEEDING;

EID: 0141851020     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)61747-6     Document Type: Article

References (44)

1. Balasch J, Tur R, Alvarez P et al. 1996 The safety and effectiveness of stepwise and low-dose administration of follicle stimulating hormone in WHO group II anovulatory infertile women: evidence from a large multicenter study in Spain. Journal of Assisted Reproduction and Genetics 13, 551-556.
2. Balen AH, Tan SL, Jacobs HS 1993 Hypersecretion of luteinising hormone: a significant cause of infertility and miscarriage. British Journal of Obstetrics and Gynaecology 100, 1082-1089.
3. Blankstein J, Shalev J, Saadon T et al. 1987 Ovarian hyperstimulation syndrome: prediction by number and size of preovulatory ovarian follicles. Fertility and Sterility 47, 597-602.
4. Brown JB 1978 Pituitary control of ovarian function - concepts derived from gonadotrophin therapy. Australia and New Zealand Journal of Obstetrics and Gynaecology 18, 46-54.
5. Dale PO, Tanbo T, Lunde O et al. 1993 Ovulation induction with low-dose follicle-stimulating hormone in women with the polycystic ovary syndrome. Acta Obstetrica et Gynecologica Scandinavica 72, 43-46.
6. Dale PO, Tanbo T, Haug E et al. 1998 The impact of insulin resistance on the outcome of ovulation induction with low-dose follicle stimulating hormone in women with polycystic ovary syndrome. Human Reproduction 13, 567-570.
7. ESHRE Capri Workshop Group 1995 Anovulatory infertility. Human Reproduction 10, 1549-1553.
8. Fauser BC, van Heusden AM 1997 Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocrine Reviews 18, 71-106.
9. Fulghesu AM, Villa P, Pavone V et al. 1997 The impact of insulin secretion on the ovarian response to exogenous gonadotropins in polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 82, 644-648.
10. Hamilton-Fairley D, Franks S 1990 Common problems in induction of ovulation. Bailliere's Clinical Obstetrics and Gynaecology 4, 609-625.
11. Hamilton-Fairley D, Kiddy D, Watson H et al. 1991 Low-dose gonadotrophin therapy for induction of ovulation in 100 women with polycystic ovary syndrome. Human Reproduction 6, 1095-1099.
12. Hamilton-Fairley D, Kiddy D, Watson H et al. 1992 Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotrophin. British Journal of Obstetrics and Gynaecology 99, 128-131.
13. Homburg R, Armar NA, Eshel A et al. 1988 Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. British Medical Journal 297, 1024-1026.
14. Homburg R, Orvieto R, Bar-Hava I et al. 1996 Serum levels of insulin-like growth factor-1, IGF binding protein-1 and insulin and the response to human menopausal gonadotrophins in women with polycystic ovary syndrome. Human Reproduction 11, 716-719.
15. Huber PJ 1967 The behavior of maximum likelihood estimates under non-standard condition. Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics, pp. 221-233.
16. Imani B, Eijkemans MJ, te Velde ER et al. 1998 Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. Journal of Clinical Endocrinology and Metabolism 83, 2361-2365.
17. Imani B, Eijkemans MJ, te Velde ER et al. 1999 Predictors of chances to conceive in ovulatory patients during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. Journal of Clinical Endocrinology and Metabolism 84, 1617-1622.
18. Imani B, Eijkemans MJ, de Jong FH et al. 2000 Free androgen index and leptin are the most prominent endocrine predictors of ovarian response during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. Journal of Clinical Endocrinology and Metabolism 85, 676-682.
19. Imani B, Eijkemans MJ, Faessen GH et al. 2002a Prediction of the individual follicle-stimulating hormone threshold for gonadotropin induction of ovulation in normogonadotropic anovulatory infertility: an approach to increase safety and efficiency. Fertility and Sterility 77, 83-90.
20. Imani B, Eijkemans MJ, te Velde ER et al. 2002b A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. Fertility and Sterility 77, 91-97.
21. Insler V 1988 Gonadotropin therapy: new trends and insights. International Journal of Fertility 33, 85-97.
22. Lass A, Vassiliev A, Decosterd G et al. 2002 Relationship of baseline ovarian volume to ovarian response in World Health Organization II anovulatory patients who underwent ovulation induction with gonadotropins. Fertility and Sterility 78, 265-269.
23. Laven JS, Imani B, Eijkemans MJ et al. 2002 New approach to polycystic ovary syndrome and other forms of anovulatory infertility. Obstetrical and Gynecological Survey 57, 755-767.
24. Little RJA 1992 Regression with missing X's: a review. Journal of the American Statistical Association 87, 1227-1237.
25. Lunenfeld B 2002 Development of gonadotrophins for clinical use. Reproductive BioMedicine Online 4 (suppl. 1), 11-17.
26. MacDougall MJ, Balen A, Jacobs HS 1992 Polycystic ovaries and their relevance to assisted infertility. In: Brinsden PR, Rainsbury PA (eds) Bourn Hall Textbook a In-vitro Fertilisation and Assisted Reproduction. Parthenon Press, London, pp. 93-110.
27. Macklon NS, Geraedts JP, Fauser BC 2002 Conception to ongoing pregnancy: the 'black box' of early pregnancy loss. Human Reproduction Update 8, 333-343.
28. McClure N, McDonald J, Kovacs GT et al. 1993 Age and follicular phase estradiol are better predictors of pregnancy outcome than luteinizing hormone in menotropin ovulation induction for anovulatory polycystic ovarian syndrome. Fertility and Sterility 59, 729-733.
29. Nelson VL, Legro RS, Strauss JF III et al. 1999 Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Molecular Endocrinology 13, 946-957.
30. Norman RJ, Davies MJ, Lord J et al. 2002 The role of lifestyle modification in polycystic ovary syndrome. Trends in Endocrinology and Metabolism 13, 251-257.
31. Pache TD, Wladimiroff JW, de Jong FH et al. 1990 Growth patterns of nondominant ovarian follicles during the normal menstrual cycle. Fertility and Sterility 54, 638-642.
32. Rowe PJ, Comhaire FH, Hargreave TB et al. 2000 Female partner. In: Rowe PJ, Comhaire FH, Hargreave TB et al. (eds) WHO Manual for the Standardized Investigation and Diagnosis of the Infertile Couple. Press Syndicate of the University of Cambridge, Cambridge, pp. 40-67.
33. Schipper I, de Jong FH, Fauser BC 1998 Lack of correlation between maximum early follicular phase serum follicle stimulating hormone concentrations and menstrual cycle characteristics in women under the age of 35 years. Human Reproduction 13, 1442-1448.
34. Schwartz M, Jewelewicz R 1981 The use of gonadotropins for induction of ovulation. Fertility and Sterility 35, 3-12.
35. van der Meer M, Hompes PG, de Boer JA et al. 1998 Cohort size rather than follicle-stimulating hormone threshold level determines ovarian sensitivity in polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 83, 423-426.
36. van Dessel HJ, Lee PD, Faessen G et al. 1999 Elevated serum levels of free insulin-like growth factor I in polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 84, 3030-3035.
37. van Santbrink EJ, Fauser BC 1997 Urinary follicle-stimulating hormone for normogonadotropic clomiphene-resistant anovulatory infertility: prospective, randomized comparison between low dose step-up and step-down dose regimens. Journal of Clinical Endocrinology and Metabolism 82, 3597-3602.
38. van Santbrink EJ, Donderwinkel PF, van Dessel TJ et al. 1995a Gonadotrophin induction of ovulation using a step-down dose regimen: single-centre clinical experience in 82 patients. Human Reproduction 10, 1048-1053.
39. van Santbrink EJ, Hop WC, van Dessel TJ et al. 1995b Decremental follicle-stimulating hormone and dominant follicle development during the normal menstrual cycle. Fertility and Sterility 64, 37-43.
40. van Santbrink EJ, Hop WC, Fauser BC 1997 Classification of normogonadotropic infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome. Fertility and Sterility 67, 452-458.
41. van Santbrink EJ, Eijkemans MJ, Macklon NS et al. 2002 FSH response-dose can be predicted in ovulation induction for normogonadotropic anovulatory infertility. Eur J Endocrinol 147, 223-226.
42. Wang CF, Gemzell C 1980 The use of human gonadotropins for the induction of ovulation in women with polycystic ovarian disease. Fertility and Sterility 33, 479-486.
43. White DM, Polson DW, Kiddy D et al. 1996 Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women. Journal of Clinical Endocrinology and Metabolism 81, 3821-3824.
44. Yarali H, Bukulmez O, Gurgan T et al. 1999 Urinary follicle-stimulating hormone (FSH) versus recombinant FSH in clomiphene citrate-resistant, normogonadotropic, chronic anovulation: a prospective randomized study. Fertility and Sterility 72, 276-281.